This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Latest news
Stay informed on our major announcements through our media releases and other updates.
-
-
-
News articles
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions. -
-
Safety updates
Refer to our articles for health professionals about health products and emerging safety issues. -
Health product safety alerts and market actions
See the latest alerts for consumers and health professionals about safety and quality issues with health products.
-
Safety alerts
Refer to the latest safety alerts for medicines or medical devices with possible risks. -
Events and consultations
Have your say on therapeutic goods regulation by participating in our public consultations or browse closed consultations. We also deliver a range of webinars, workshops and meetings on areas of interest for industry, consumers, and health professionals.
-
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals. -
Events
Search our upcoming and past events including webinars, committee meetings, presentations, and workshops.
Our subscription services
Stay connected and sign up to our RSS news feeds and email subscription services to receive real-time updates on our latest news, product shortage alerts, and media releases as we publish them, or subscribe to monthly updates.
-
Email subscriptions
We offer several email subscription options to keep you up to date with news and alerts. -
RSS feeds
RSS feeds (Really Simple Syndication feed) for immediate notifications of updates to the TGA website.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
GLP-1 RAs and rare vision disorder
Safety updatesProduct warnings across the glucagon-like-peptide-1 receptor agonist (GLP-1 RA) class of medicines have been updated due to the potential for these products to cause a rare, but severe, form of eye disorder. -
July 2026 updates to the list of decisions for Australian manufacturers licensed by the TGA
Regulatory decision noticesWe have added our recent decisions to the list of Australian manufacturers licensed by the TGA. -
Product Information safety updates - June 2026
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
Latest publications
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #47 meeting held in June 2025
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #47 and Joint ACMS-ACCS #40 meetings held in June 2025
-
Meeting statementsAdvisory Committee on Medicines meeting statement
Latest consultations
-
ConsultationWe are seeking feedback on proposed changes to improve the Therapeutic Goods Advertising Code.
-
ConsultationWe are seeking feedback on proposed changes to publishing information about Good Manufacturing Practice (GMP) compliance on our website.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.